Oregon’s attorney general filed a lawsuit Wednesday against three insulin manufacturers and the nation’s largest pharmacy ...
Oregon's Attorney General sues insulin manufacturers and PBMs for $900 million, alleging price inflation and collusion, ...
Attorney General Dan Rayfield accused some of the world’s largest pharmaceutical companies of conspiring to artificially ...
The Philadelphia region’s largest health system has sued several drugmakers and pharmacy benefit managers, alleging ...
Philadelphia-based Jefferson Health and Thomas Jefferson University filed a federal lawsuit Dec. 30 alleging that three insulin manufacturers and the nation’s largest pharmacy benefit managers ...
Eli Lilly and Company has entered a definitive agreement to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage ...
Filed under Oregon’s consumer protection law, the suit accuses drugmakers and pharmacy benefit managers of conspiring to ...
Oregon Attorney General Dan Rayfield filed a $900 million lawsuit against the nation's largest insulin manufacturers, ...
The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...
Stocktwits on MSN
Eli Lilly to acquire Ventyx Biosciences in $1.2 billion deal
Eli Lilly and Company (LLY) said on Wednesday that it would acquire Ventyx Biosciences (VTYX) in a deal worth $1.2 billion.
The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback